Revised SPC: Clarelux (clobetasol propionate) 500 microgram/g cutaneous foam in pressurised container

SPC has been updated with warning that prolonged use may result in serious undesirable effects;if treatment with local corticosteroid (CS) is clinically justified beyond 2weeks, a less potent CS should be considered. Repeated but short courses may be used to control exacerbations

Source:

electronic Medicines compendium